Pliant Therapeutics, Inc.
PLRX
$1.33
$0.021.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 190.94M | 241.80M | 262.87M | 305.65M | 355.72M |
| Total Receivables | 823.00K | 908.00K | 1.54M | 1.68M | 2.30M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.79M | 1.76M | 1.28M | 1.72M | 2.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.90M | 1.13M | 1.76M | 2.14M | 1.26M |
| Total Current Assets | 196.45M | 245.59M | 267.44M | 311.19M | 362.26M |
|
|
|||||
| Total Current Assets | 196.45M | 245.59M | 267.44M | 311.19M | 362.26M |
| Net Property, Plant & Equipment | 26.91M | 29.14M | 30.51M | 31.67M | 32.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.87M | 1.87M | 1.87M | 1.91M | 1.92M |
| Total Assets | 225.23M | 276.60M | 299.82M | 344.77M | 396.95M |
|
|
|||||
| Total Accounts Payable | 480.00K | 485.00K | 1.38M | 5.62M | 5.96M |
| Total Accrued Expenses | 14.44M | 15.95M | 17.98M | 21.81M | 26.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.45M | 1.19M | 1.23M | 771.00K | 542.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.37M | 17.62M | 20.59M | 28.20M | 33.22M |
|
|
|||||
| Total Current Liabilities | 16.37M | 17.62M | 20.59M | 28.20M | 33.22M |
| Long-Term Debt | -- | 30.44M | 30.36M | 30.28M | 30.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.66M | 28.23M | 28.79M | 29.12M | 29.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 44.02M | 76.29M | 79.74M | 87.61M | 92.87M |
|
|
|||||
| Common Stock & APIC | 1.04B | 1.04B | 1.03B | 1.02B | 1.01B |
| Retained Earnings | -859.40M | -835.82M | -809.52M | -766.22M | -710.05M |
| Treasury Stock & Other | -15.00K | 34.00K | -1.00K | 159.00K | 321.00K |
| Total Common Equity | 181.21M | 200.31M | 220.08M | 257.16M | 304.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 181.21M | 200.31M | 220.08M | 257.16M | 304.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 181.21M | 200.31M | 220.08M | 257.16M | 304.08M |
|
|
|||||